AFP and neoplasm: Although early post-treatment changes in AFP levels were not predictive of tumor recurrence—likely due to the temporal gap between sample collection and recurrence events—longitudinal monitoring of AFP levels in cfDNA enabled the detection of recurrence and facilitated the evaluation of treatment outcomes.